HealthDay

FDA Head Says Feds May Intervene to Cut Vaccine Exemptions

WEDNESDAY, Feb. 20, 2019 (Pharmacist's Briefing) -- The U.S. government may have to take steps to reduce vaccine exemptions for children if states do not do it, the head of the U.S. Food and Drug Administration suggested. His comments come as measles outbreaks rage in a number of states. Those outbreaks could have been prevented if children had all been vaccinated. But nearly all states allow children to attend school even if their parents opt out of inoculation programs, CNN reported
Read More

HealthDay

Inappropriate Use of Fentanyl Preps Seen Despite Awareness

TUESDAY, Feb. 19, 2019 (Pharmacist's Briefing) -- Despite adequate levels of prescriber, pharmacist, and patient knowledge regarding transmucosal immediate-release fentanyls (TIRFs), the rates of inappropriate use are high, according to a study published in the Feb. 19 issue of the Journal of the American Medical Association
Read More

HealthDay

Medicare Patients With MS Face Higher Out-of-Pocket Rx Costs

THURSDAY, Feb. 14, 2019 (Pharmacist's Briefing) -- Medicare patients with multiple sclerosis (MS) face increasing out-of-pocket costs for disease-modifying therapies, according to a study published in the February issue of Health Affairs
Read More

HealthDay

High Rates of MenB Vaccination Advised in University Outbreaks

THURSDAY, Feb. 14, 2019 (Pharmacist's Briefing) -- Achieving high serogroup B meningococcal (MenB) vaccination coverage is recommended following university-based outbreaks of meningococcal disease caused by serogroup B, according to a study published online Feb. 13 in the U.S. Centers for Disease Control and Prevention Emerging Infectious Diseases
Read More

HealthDay

Drug Company Payments Over Time May Influence Rx Practices

WEDNESDAY, Feb. 13, 2019 (Pharmacist's Briefing) -- Physicians treating certain cancers who consistently receive payments from a cancer drug's manufacturer are more likely to prescribe that drug instead of other treatments, according to a study published online Feb. 6 in The Oncologist
Read More

HealthDay

Health Care Spending Per Person Increased to $5,641 in 2017

TUESDAY, Feb. 12, 2019 (Pharmacist's Briefing) -- In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report
Read More

HealthDay

FDA Warns 17 Companies About Illegal Alzheimer Disease Products

MONDAY, Feb. 11, 2019 (Pharmacist's Briefing) -- A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat, or cure Alzheimer disease and other serious conditions, the U.S. Food and Drug Administration says
Read More

HealthDay

Measles Outbreak Triggers Sharp Rise in Demand for Vaccine

FRIDAY, Feb. 8, 2019 (Pharmacist's Briefing) -- Health clinics in Clark County, Washington, are scrambling to meet the sharply increased demand for measles vaccination as people seek protection during an outbreak of the highly contagious virus
Read More

HealthDay

Johnson & Johnson to Provide Drug Prices in TV Ads

FRIDAY, Feb. 8, 2019 (Pharmacist's Briefing) -- In a drug industry first, Johnson & Johnson will start giving the list prices of its prescription drugs in television ads
Read More

HealthDay

FDA Approves Cablivi for Rare Blood-Clotting Disorder

WEDNESDAY, Feb. 6, 2019 (Pharmacist's Briefing) -- Cablivi (caplacizumab-yhdp) injection has been approved by the U.S. Food and Drug Administration to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Read More

HealthDay

Amazon One Step Closer to the Prescription Business

TUESDAY, Feb. 5, 2019 (Pharmacist's Briefing) -- PillPack's Arizona facility has been granted pharmacy licenses in nine states, bringing its reach to 19, according to Jefferies Equity Research. The location also has three additional state licenses pending approval.
Read More

HealthDay

Expanded Recall of Warfarin Level Monitoring Test Strips

MONDAY, Feb. 4, 2019 (Pharmacist's Briefing) -- Certain lots of Roche Diagnostics test strips should not be used with CoaguChek test meter devices to check levels of the blood thinner warfarin because patients may get inaccurate results and be at risk for serious injury or death, the U.S. Food and Drug Administration says in an updated recall notice
Read More

HealthDay

Updated ACIP Immunization Schedule Released for Adults

MONDAY, Feb. 4, 2019 (Pharmacist's Briefing) -- The Advisory Committee on Immunization Practices has released its updated adult immunization schedule for 2019; the schedule was published online Feb. 5 in the Annals of Internal Medicine
Read More

HealthDay

FDA Grants "First Generic" Drug Approvals for 2019

MONDAY, Feb 4, 2019 (Pharmacist's Briefing) The Food and Drug Administration's Center for Drug Evaluation and Research has kicked off 2019 with several "first generic" drug approvals. The center's primary task is to review and allow for safe, effective, high-quality generic alternatives to be marketed, which in turn creates more affordable treatment options for patients
Read More

HealthDay

FDA Approves First Generic Version of Advair for Asthma, COPD

THURSDAY, Jan. 31, 2019 (Pharmacist's Briefing) -- The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration
Read More

HealthDay

Expanded Recall Announced for Ibuprofen Oral Suspension Drops

WEDNESDAY, Jan. 30, 2019 (Physician's Briefing) -- An expanded recall of ibuprofen oral suspension drops that may contain higher-than-specified levels of ibuprofen that could harm infants' kidneys has been announced by Tris Pharma, Inc
Read More

HealthDay

New CDC Tracker Shows Lower Influenza Burden This Season

WEDNESDAY, Jan. 30, 2019 (Pharmacist's Briefing) The U.S. Centers for Disease Control and Prevention is providing in-season influenza activity totals for the first time, and the news is good
Read More

HealthDay

Large Insulin Price Hike to Be Investigated by U.S. Congress

TUESDAY, Jan. 29, 2019 (Pharmacist's Briefing) -- The soaring cost of insulin will be investigated as the U.S. Congress holds hearings into the high cost of prescription drugs, a lawmaker says
Read More

HealthDay

Virtual Video Visits Liked by Patients, Providers

FRIDAY, Jan. 25, 2019 (Pharmacist's Briefing) -- Virtual video visits can effectively replace office visits for selected patients across medical specialties without sacrificing quality of care or patient-physician communication, according to a study published in the January issue of the American Journal of Managed Care
Read More

HealthDay

Prostate Drug Finasteride Can Safely Lower Cancer Risk, Study Says

THURSDAY, Jan. 24, 2019 (Pharmacist's Briefing) -- Finasteride, best known as the enlarged-prostate medicine Proscar, is a safe, effective way to reduce the risk of prostate cancer, according to long-term findings from the Prostate Cancer Prevention Trial (PCPT)
Read More

HealthDay

CDC: Opioid Prescribing Higher in Rural Versus Urban Areas

TUESDAY, Jan. 22, 2019 (Pharmacist's Briefing) -- The percentage of individuals prescribed an opioid is higher in rural than urban areas, according to research published in the Jan. 18 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report
Read More

HealthDay

FDA Impacted by Government Shutdown

SATURDAY, Jan. 19, 2019 (Pharmacist's Briefing) --The government shutdown, if it continues beyond February 11th, will begin to impact the Food and Drug Administration in a big way. Product approval, a major function of the FDA, will decline if an agreement isn't reached before then.
Read More

HealthDay

Walmart and CVS reach agreement for CVS Caremark insured patients

SATURDAY, Jan. 19, 2019 (Pharmacist's Briefing) --CVS and Walmart reached an agreement which will allow patients to obtain prescription services at Wal Mart pharmacy locations. While exact terms were undisclosed, the deal allows Walmart pharmacies to accept CVS Caremark insurance as payment for services, as part of a multiyear agreement. Both companies were at risk for potentially huge losses; Walmart risked losing thousands of patients, as they typically go to pharmacies where their insurance is accepted. CVS recently announced a strategy to provide patients with an "under one roof " offering all health services in a single location, which hinges on relationships with large employer groups and other insurers. The loss of a large agreement like the Walmart/CVS Caremark contract would have proven expansion into this area difficult. The agreement allows patients to continue to receive pharmacy services without a potential gap in therapy
Read More

HealthDay

FDA Panel Has Tie Vote on New Type 1 Diabetes Drug

FRIDAY, Jan. 18, 2019 (Pharmacist's Briefing) -- A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for type 1 diabetes ended in an 8-8 tie Thursday
Read More

HealthDay

1 in 4 Antibiotic Prescriptions Isn't Needed: Study

THURSDAY, Jan. 17, 2019 (Pharmacist's Briefing) -- Nearly 25 percent of antibiotics prescribed in the United States are given for conditions they aren't meant to treat, a new study finds.
Read More

HealthDay

Opioids Now More Deadly for Americans Than Traffic Accidents

TUESDAY, Jan. 15, 2019 (Pharmacist's Briefing) -- For the first time in history, Americans' risk for dying from an opioid overdose is higher than their risk for dying in a car accident, the National Safety Council reported Monday
Read More

HealthDay

800-662-HELP Underappreciated in Media, General Population

MONDAY, Jan. 14, 2019 (Pharmacist's Briefing) -- The Substance Abuse and Mental Health Services Administration national helpline (800-662-HELP) seems to be underappreciated in the media and by the general population, according to a research letter published online Jan. 14 in JAMA Internal Medicine
Read More

HealthDay

Expanding Pharmacist Practice Scope Could Reduce ED Overcrowding

MONDAY, Jan. 14, 2019 (Pharmacist's Briefing) -- The introduction of emergency department- or community-based pharmacists with an expanded scope of practice may cut emergency department overcrowding, according to a study recently published in Research in Social and Administrative Pharmacy
Read More

HealthDay

Prices Still Explain High U.S. Health Care Spending

FRIDAY, Jan. 11, 2019 (Pharmacist's Briefing) -- The difference in health spending between the United States and other countries is still explained by health care prices, according to a study published in the January issue of Health Affairs
Read More

HealthDay

Changes to Flu Shot Supply Chain Could Save Lives: Study

FRIDAY, Jan. 11, 2019 (Pharmacist's Briefing) -- Problems with flu vaccine distribution in the United States may cost lives and pose a serious threat in the event of a flu pandemic, researchers warn
Read More